NUVL
Nuvalent, Inc.
NASDAQ · USHealthcareBiotechnology
$123.96+0.00%
Price as of Jul 14, 2026
NUVL earnings
Nuvalent, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 6, 2026in NaN days
EPS est $-1.44 · Revenue est $245455
Track record
Beat EPS in 2 of 12 quarters
Avg surprise -8.0% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 7, 2026 | $-1.35 | $-1.39 | -3.0% | — | — |
| Oct 30, 2025 | $-1.39 | $-1.70 | -22.3% | — | — |
| Aug 7, 2025 | $-1.27 | $-1.31 | -3.1% | — | — |
| May 8, 2025 | $-1.14 | $-1.18 | -3.5% | — | — |
| Feb 27, 2025 | $-1.04 | $-1.05 | -1.0% | — | — |
| Aug 8, 2024 | $-0.76 | $-0.88 | -15.8% | — | — |
| May 9, 2024 | $-0.67 | $-0.69 | -3.0% | — | — |
| Feb 27, 2024 | $-0.59 | $-0.62 | -5.1% | — | — |
| Nov 14, 2023 | $-0.59 | $-0.59 | +0.0% | — | — |
| Aug 10, 2023 | $-0.53 | $-0.51 | +3.8% | — | — |
| May 11, 2023 | $-0.51 | $-0.44 | +13.7% | — | — |
| Mar 16, 2023 | $-0.43 | $-0.49 | -14.0% | — | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-06.